Mindy Magee

机构：GlaxoSmithKline (United States), Simulation Technologies (United States), Kalamazoo College

发表论文 51 篇 · 总被引 811 次 · h-index 15

代表论文

Industrial Perspective on the Benefits Realized From the FDA’s Model‐Informed Drug Development Paired Meeting Pilot Program (2021 · Clinical Pharmacology & Therapeutics · 被引 23)
Considerations for Industry—Preparing for the FDA Model‐Informed Drug Development (MIDD) Paired Meeting Program (2024 · Clinical Pharmacology & Therapeutics · 被引 17)
Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants (2022 · Antimicrobial Agents and Chemotherapy · 被引 15)
Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of Fostemsavir (2020 · The Journal of Clinical Pharmacology · 被引 13)
A Quantitative Clinical Pharmacology-Based Framework For Model-Informed Vaccine Development (2023 · Journal of Pharmaceutical Sciences · 被引 11)
Pharmacokinetics, metabolism and excretion of radiolabeled fostemsavir administered with or without ritonavir in healthy male subjects (2022 · Xenobiotica · 被引 11)